GLP-1 Maintenance: What Happens When You Lower Your Dose, Switch Medications, or Stop Entirely

About this episode

The episode discusses the effects of lowering GLP-1 medication doses and switching medications after weight loss, based on new clinical trial data.

2:26 PMClaude responded: Dr.Dr. Spencer Nadolsky and Karl break down two brand new randomized controlled trials, Surmount-Maintain and Attain-Maintain, that put hard numbers on what actually happens to patients when they try to lower their tirzepatide dose, switch to oral orforglipron, or come off GLP-1 medicines entirely after significant weight loss. The data confirms what they have been seeing clinically for years: obesity biology fights hard to pull weight back up, only about 17 percent of people can come off these medicines and maintain their results, and for most patients the conversation is not about stopping but about finding the most effective and affordable long-term dosing strategy.

People in this episode

Host: Karl

Guest: Dr. Spencer Nadolsky

Topics covered

• GLP-1 medications
• weight loss
• obesity biology
• dosing strategies
• clinical trials

Keywords

• GLP-1
• tirzepatide
• orforglipron
• weight maintenance
• obesity
• clinical trials
• dosing strategy

Mentioned in this episode

Products: tirzepatide, orforglipron

More episodes of Docs Who Lift

• Retatrutide Phase 3 Results: What the Data Actually Means · June 8, 2026 · 45 min
• Are GLP-1 Medicines Shredding Your Bones? Here Is What the Actual Evidence Says With Dr. Susan Brian · May 18, 2026 · 32 min
• Heavy Metal Toxicity: Separating Real Risks From Influencer Scams | Dr. Eryn Russo · May 5, 2026 · 53 min
• GLP-1 Genetics: Predicting Weight Loss and Side Effects With 23andMe's Dr. Adam Auton · April 21, 2026 · 25 min
• Do GLP-1 Medicines Actually Cause Muscle Loss? New Research With Dr. Henning Langer · April 14, 2026 · 36 min
• How Often Should You Really Lift Weights? Feat. Dr. Stuart Phillips · April 2, 2026 · 52 min